First-Line Treatment Strategies to Improve Survival in Patients with Advanced Colorectal Cancer

By Gill S.  

Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. : 27-44

Adis International

Access to resources Recommend Favorite

Targeting Vascular Endothelial Growth Factor Pathway in First-Line Treatment of Metastatic Colorectal Cancer: State-of-the-Art and Future Perspectives in Clinical and Molecular Selection of Patients

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-02 ,pp. : 37-45

Bentham Science Publishers

Access to resources Recommend Favorite

Bevacizumab: In First-Line Treatment of Metastatic Breast Cancer

By Scott Lesley J.  

Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. : 1793-1799

Adis International

Access to resources Recommend Favorite

Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancer

By Yamada Yasuhide  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1690-1696

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine monotherapy is an effective and well tolerated first-line treatment for patients with advanced or metastatic gastric cancer

By  

Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite